Literature DB >> 2505958

High interleukin-6 serum levels and increased production by leucocytes in alcoholic liver cirrhosis. Correlation with IgA serum levels and lymphokines production.

J Deviere1, J Content, C Denys, P Vandenbussche, L Schandene, J Wybran, E Dupont.   

Abstract

Hypergammaglobulinaemia and enhanced serum IgA levels are common in alcoholic liver cirrhosis. Interleukin-6 (IL-6), which is identical to B cell differentiation factor BSF2 and is implicated in various autoimmune diseases, has been studied in patients with alcoholic liver cirrhosis. Increased serum levels and spontaneous or induced production of IL-6 by peripheral blood monoclonal cells have been found. IL-6 production correlates closely with IgA serum levels and negatively with impaired interleukin-2 and interferon gamma production. This abnormality could be related to overproduction of immunoglobulins and immune disturbances observed in this disease.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2505958      PMCID: PMC1541981     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  26 in total

1.  Bacterial lipopolysaccharide and inflammatory mediators augment IL-6 secretion by human endothelial cells.

Authors:  F R Jirik; T J Podor; T Hirano; T Kishimoto; D J Loskutoff; D A Carson; M Lotz
Journal:  J Immunol       Date:  1989-01-01       Impact factor: 5.422

Review 2.  Histologic spectrum of alcoholic liver disease.

Authors:  R N MacSween; A D Burt
Journal:  Semin Liver Dis       Date:  1986-08       Impact factor: 6.115

3.  Activation of the human beta-interferon gene requires an interferon-inducible factor.

Authors:  T Enoch; K Zinn; T Maniatis
Journal:  Mol Cell Biol       Date:  1986-03       Impact factor: 4.272

4.  Hyperglobulinaemia in liver disease.

Authors:  D R Triger; R Wright
Journal:  Lancet       Date:  1973-06-30       Impact factor: 79.321

5.  Helper and suppressor T lymphocyte function in severe alcoholic liver disease.

Authors:  U McKeever; C O'Mahony; C A Whelan; D G Weir; C Feighery
Journal:  Clin Exp Immunol       Date:  1985-04       Impact factor: 4.330

6.  Human B-cell differentiation factor defined by an anti-peptide antibody and its possible role in autoantibody production.

Authors:  T Hirano; T Taga; K Yasukawa; K Nakajima; N Nakano; F Takatsuki; M Shimizu; A Murashima; S Tsunasawa; F Sakiyama
Journal:  Proc Natl Acad Sci U S A       Date:  1987-01       Impact factor: 11.205

7.  Interleukin 2 activity in chronic liver disease and the effect of in vitro alpha-interferon.

Authors:  S Saxena; K T Nouri-Aria; M G Anderson; A L Eddleston; R Williams
Journal:  Clin Exp Immunol       Date:  1986-03       Impact factor: 4.330

8.  Structural analysis of the sequence coding for an inducible 26-kDa protein in human fibroblasts.

Authors:  G Haegeman; J Content; G Volckaert; R Derynck; J Tavernier; W Fiers
Journal:  Eur J Biochem       Date:  1986-09-15

9.  Impaired concanavalin A-inducible suppressor T-cell activity in active alcoholic liver disease.

Authors:  H Kawanishi; H Tavassolie; R P MacDermott; J N Sheagren
Journal:  Gastroenterology       Date:  1981-03       Impact factor: 22.682

10.  Purification and NH2-terminal amino acid sequence of a T-cell-derived lymphokine with growth factor activity for B-cell hybridomas.

Authors:  J Van Snick; S Cayphas; A Vink; C Uyttenhove; P G Coulie; M R Rubira; R J Simpson
Journal:  Proc Natl Acad Sci U S A       Date:  1986-12       Impact factor: 11.205

View more
  48 in total

Review 1.  Interleukin-6 and insulin sensitivity: friend or foe?

Authors:  A L Carey; M A Febbraio
Journal:  Diabetologia       Date:  2004-07-07       Impact factor: 10.122

2.  Pegylated interferon α-2b up-regulates specific CD8+ T cells in patients with chronic hepatitis B.

Authors:  Ji Chen; Yan Wang; Xue-Jie Wu; Jun Li; Feng-Qin Hou; Gui-Qiang Wang
Journal:  World J Gastroenterol       Date:  2010-12-28       Impact factor: 5.742

Review 3.  Immunological response in alcoholic liver disease.

Authors:  Michael J Duryee; Lynell W Klassen; Geoffrey M Thiele
Journal:  World J Gastroenterol       Date:  2007-10-07       Impact factor: 5.742

4.  Identification of liver cancer progenitors whose malignant progression depends on autocrine IL-6 signaling.

Authors:  Guobin He; Debanjan Dhar; Hayato Nakagawa; Joan Font-Burgada; Hisanobu Ogata; Yuhong Jiang; Shabnam Shalapour; Ekihiro Seki; Shawn E Yost; Kristen Jepsen; Kelly A Frazer; Olivier Harismendy; Maria Hatziapostolou; Dimitrios Iliopoulos; Atsushi Suetsugu; Robert M Hoffman; Ryosuke Tateishi; Kazuhiko Koike; Michael Karin
Journal:  Cell       Date:  2013-10-10       Impact factor: 41.582

Review 5.  Role of retinoic acid in the imprinting of gut-homing IgA-secreting cells.

Authors:  J Rodrigo Mora; Ulrich H von Andrian
Journal:  Semin Immunol       Date:  2008-09-18       Impact factor: 11.130

6.  Localisation of intrahepatic interleukin 6 in patients with acute and chronic liver disease.

Authors:  S Kakumu; A Fukatsu; T Shinagawa; S Kurokawa; A Kusakabe
Journal:  J Clin Pathol       Date:  1992-05       Impact factor: 3.411

7.  Interleukin-6 and its soluble receptor in patients with liver cirrhosis and hepatocellular carcinoma.

Authors:  Maurizio Soresi; Lydia Giannitrapani; Fabio D'Antona; Ada-Maria Florena; Emanuele La Spada; Angela Terranova; Melchiorre Cervello; Natale D'Alessandro; Giuseppe Montalto
Journal:  World J Gastroenterol       Date:  2006-04-28       Impact factor: 5.742

Review 8.  Alcohol abuse and pulmonary disease.

Authors:  Darren M Boé; R William Vandivier; Ellen L Burnham; Marc Moss
Journal:  J Leukoc Biol       Date:  2009-07-14       Impact factor: 4.962

9.  Alcohol screening scores and 90-day outcomes in patients with acute lung injury.

Authors:  Brendan J Clark; André Williams; Laura M Cecere Feemster; Katharine A Bradley; Madison Macht; Marc Moss; Ellen L Burnham
Journal:  Crit Care Med       Date:  2013-06       Impact factor: 7.598

10.  Evaluation of sequential serum interleukin-6 levels in liver allograft recipients.

Authors:  Y Kita; Y Iwaki; A J Demetris; T E Starzl
Journal:  Transplantation       Date:  1994-04-15       Impact factor: 4.939

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.